DOCSLIB.ORG

Meet the Cohort 2019–20

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Meet the Cohort 2019–20 MEET THE COHORT 2019–20 SUPPORTED BY PARTNERS CONTENTS 03 FOREWORD 04 ABOUT THE ACCELERATOR 06 OUR IMPACT 08 MEET THE INNOVATORS 15 NHS CASE STUDIES 18 OUR ALUMNI 21 MEET THE NHS CHAMPIONS AND MENTORS 29 MEET THE TEAM 30 HOW CAN WE HELP YOU? 31 THANK YOU 02 MEET THE COHORT 2019–20 FOREWORD DigitalHealth.London Accelerator team As we enter the fourth year of the DigitalHealth.London Accelerator, and introduce you to our latest game-changing set of innovators, we want to take a moment to look back as well as forward. Our founding partners shared a vision when We don’t expect the NHS to “transform” they created the Accelerator: that the needs on its own. We know this is a challenging of the NHS - patients, staff, and taxpayers - process with barriers that can sometimes must be at the heart of everything we do. It’s make it feel like an insurmountable task. in our DNA, and something we’re proud to That is why we’re delighted to have hold at our core each and every year. collaborated for another year with more than 100 NHS professionals from across Our support focuses on digital innovations London to select a group of innovators that that can make a real difference. They have has real potential to help face down some covered some of the newest and most of their biggest issues and help deliver exciting areas in digital health – AI, virtual the changes set out in the NHS Long Term reality, big data, bionics – but, crucially, they Plan. Collaboratively, these innovators give have also reflected the urgent need to get us a strong chance at making real and the basics right. We are not only about the lasting change to the way NHS services are buzzwords, and are committed to the ideal delivered – how easily staff can do their jobs, that technology is not an add-on, but an how conveniently patients can look after integral part of the NHS’s future. themselves and their families, and how much more efficiently we can take advantage of the The NHS Long Term Plan says that, resources and information at our fingertips. “technology is continually opening up new possibilities for prevention, care and If, when learning about them, you feel any of treatment.” Using it in our daily lives can (and the innovations outlined in this booklet could already does) make things easier, quicker, make a difference to your organisation, get and more efficient. There’s no reason why this in touch – we’d love to help make it a reality. shouldn’t also be the case in health and care. MEET THE COHORT 2019–20 03 1 | ABOUT THE ACCELERATOR London is not only a global centre for business, entrepreneurial thinking and technological innovation; it is a thriving hub for healthcare. But despite the array of talent and resources, there is room for better collaboration between SMEs and the health system to increase competitiveness in digital innovation. DigitalHealth.London’s Accelerator was set up to help small and medium-sized enterprises “It makes us very confident in the (SMEs) accelerate the adoption of digital fact that (the companies) have health innovations into the NHS by giving innovators improved access to the wealth of come through the programme, world-class research, medical technology, so we know that we’re getting a and resources London has to offer. vetted company, and when we start out, we don’t have to vet This year it will work with 20 high potential SMEs, and support them to develop and them ourselves. It gives us that deploy solutions to some of the most great confidence to start with.” pressing challenges facing the NHS. We Helen Wormald will help them understand demand, test innovations from an early stage, and bring Matron for Transformation, new products and processes to market. King’s College Hospital NHS Foundation Trust “The DigitalHealth.London Accelerator is part of a long- overdue digital revolution in the NHS. We must create a system whereby healthtech innovators are supported and can really feel our commitment to them and their ground-breaking work. This programme does just that, plus it supports the NHS and social care to make the most of the digital opportunity.” Tara Donnelly Chief Digital Officer, NHSX 04 MEET THE COHORT 2019–20 1 | “The NHS and our partners in London have a vision to be the healthiest global city and the best place to receive health and care. This means that we must have a digitally enabled health and care system and a city which promotes and supports “The DigitalHealth.London innovation and research. The Accelerator is a good example DigitalHealth.London Accelerator of a programme designed and makes the most of London’s delivered by the AHSNs, that not fantastic combination of only helps tackle NHS challenges world-class universities, NHS and but also supports economic entrepreneurial spirit, to develop growth, through supporting the and test solutions to help rapid uptake of innovations.” support the patient and our local communities now and in the future.” Dr Sam Roberts Sir David Sloman Chief Executive of the Accelerated Access London Regional Director, Collaborative, NHS England NHS Improvement “I am delighted to support the Accelerator and this latest intake of digital health companies looking to bring their innovations to Londoners. The programme’s work ensures that London is at the forefront of digital innovation, and is vital to building a future where its citizens benefit from the latest technologies to support their health.” Theo Blackwell Chief Digital Officer for London MEET THE COHORT 2019–20 05 OUR IMPACT Our work with more than 80 trusted innovators has been recognised in several ways this year, including on a CNN feature, a 2019 HealthInvestor Award for our partnership with the NHS, and a listing by the Financial Times’ new venture, Sifted, as one of the “best healthtech accelerators in Europe.” ll e w g n i e g A e c r o f k r o W *All above figures are self-reported: 61 SMEs from cohorts **The Net Promoter Score range is -100 to +100, a score of one and two were asked to complete an impact survey, which above 50 is in the “excellent” category. had a 67% response rate. 06 MEET THE COHORT 2019–20 MEET THE INNOVATORS We select companies for the Accelerator that address real challenges faced by NHS organisations. The below diagram shows how this year’s Accelerator participants map onto the NHS Long Term Plan priorities. Some companies work on more than one area, so although we have chosen their primary areas of focus to display here, they may also cover other areas within the Long Term Plan. isease Dec ar d ision cul su as pp iov or rd t Ca W o rk fl o ll w e m w a g n n i a e g g e m A e n t A c LONG TERM PLAN c e s e s c r t o o f s k r e r o v W i c e s t n e m C e an g c a er an m lf Se Lifestyle choices MEET THE COHORT 2019–20 07 CASE STUDY: working with London NHS trusts to bring in new digital innovations The Accelerator works in partnership with NHS organisations from STP level right down to clinic level, helping to find digital solutions and support implementation where needed. This year, we have worked with teams at The Royal Brompton and The Royal Marsden to tackle challenges around outpatient clinics and research. At the Royal Brompton, we helped curate an As a result of the event, conversations event exploring solutions that could fulfil the between four different SMEs, The Royal need for more efficient, virtual, outpatient Marsden and the Institute of Cancer Research clinics. We wanted to show attendees how are in progress. One of the Accelerator technology could support them to deliver care companies, Trustedoctor, is exploring how to patients in different ways. Two companies it could allow easier collaboration between from the DigitalHealth.London Accelerator specialists and multi-disciplinary cancer teams presented: online consultation platform through a platform that allows report, data, provider Q doctor; and Visionable, which and radiological image sharing, as well an enables clinicians to connect to one other and integrated video functionality. their patients, while simultaneously sharing data and images over a secure connection. A stone’s throw away, the NIHR Biomedical Research Centre (BRC) at The Royal Marsden and the Institute of Cancer Research was looking to create new collaborations with digital technology providers to help address some of its challenges around developing and testing tech, grant applications, and research. The BRC invited the DigitalHealth.London Accelerator to collaborate around a digital “Dragons’ Den” event, whereby innovators introduced their work to the BRC and Royal Marsden decision-makers at an interactive session. Ten companies, five of which were from the DigitalHealth.London Accelerator and one from the sister South West AHSN Digital Health Accelerator, were invited to present Learn more about Q doctor their innovations. The panel was made up www.qdoctor.io | @Qdoctor_io of the CIO and COO of The Royal Marsden, representatives from radiology, robotics, Learn more about Visionable cancer research, and patients. www.visionable.com | @VisionableG Learn more about Trustedoctor www.trustedoctor.com | @trustedoctor 08 MEET THE COHORT 2019–20 CASE STUDY: an adaptable approach to digital health partnerships in primary care Through the General Practice Forward View, the £45M GP Online Consultation Systems Fund has been made available for GP practices across the country, to explore ways of providing online consultations for their patients.
Load more

Recommended publications
  • Uclpartners Academic Health Science Partnership
    UCLPartners academic health science partnership Professor the Lord Ajay Kakkar, Chair, UCLPartners Professor Sir David Fish, Managing Director, UCLPartners Dr Charlie Davie, Director of UCLPartners AHSN Clare Panniker, Chief Executive, Basildon and Thurrock University Hospitals NHS Foundation Trust What is UCLPartners? Six million population 23 healthcare organisations acute and 11 higher education institutes mental health trusts; community providers and research networks 20 Clinical Commissioning Groups (CCGs) Industry partnerships in research and 26 boroughs and local councils translation of innovation into health and wealth 2 Local Enterprise Partnership – key challenge • Working with the London Enterprise Panel, established by the Mayor of London • Professor Stephen Caddick, Vice Provost (Enterprise), UCL, is the only academic representative on the Panel • Key challenges of the panel: to compete with Boston and San Francisco; improve access to the NHS market to increase venture capital • How UCLPartners is contributing: working with industry to co-create technology and devices; creating long-term partnerships with industry and giving confidence to entrepreneurs, e.g. through new business models and procurement initiatives • Other areas of joint working: MedCity, Care City, London Health Commission, three London AHSNs and preparing to enable the success of the Francis Crick Institute 3 Defragmenting the pathway – an integrated journey to transform healthcare through innovation into practice Bringing together formal designations under
    [Show full text]
  • The Proposed Merger of Ealing Hospital NHS Trust and the North West London Hospitals NHS Trust Full Business Case Version 15
    The proposed merger of Ealing Hospital NHS Trust and The North West London Hospitals NHS Trust Full Business Case Version 15: 20th June 2014 Table of Contents Table of Contents ................................................................................................ i List of Tables ...................................................................................................... v List of Figures .................................................................................................. vii Abbreviations .................................................................................................. viii 0. Executive Summary ................................................................................... 1 0.1 Background ........................................................................................................ 1 0.2 The case for change ........................................................................................... 1 0.3 London North West Healthcare – What will day 1 feel like? ................................ 2 0.4 London North West Healthcare - What will be different for patients? .................. 3 0.5 Conclusion ......................................................................................................... 3 1. Introduction................................................................................................. 4 1.1 Background to the FINAL business case ............................................................ 4 1.2 Strategic context ................................................................................................
    [Show full text]
  • PULSE: Speaker Biographies March 2019
    PULSE: Speaker Biographies March 2019 Supported by @BIA_UK www.bioindustry.org In order of appearance: Dr Barbara Domayne-Hayman Entrepreneur-in-residence, Francis Crick Institute, CBO, Autifony Therapeutics Ltd and formerly Chairman, Puridify Barbara has worked on the commercial side of life sciences for thirty years, first in a large organisation (ICI/Zeneca/AstraZeneca), before transitioning to the entrepreneurial world of biotech. Barbara joined the Francis Crick Institute in January 2018 as Entrepreneur-in- residence. She is also Chief Business officer of Autifony, where she is responsible for strategic partnering, fundraising and commercial aspects of drug development for CNS disorders. In December 2017 Autifony signed a major collaboration with Boehringer Ingelheim. Barbara was also Chair of Puridify, a UCL spin-out with a breakthrough biotherapeutics purification technology, which was acquired by GE in November 2017. She chairs the LifeArc Seed Fund investment committee, and is on the Cambridge Enterprise Seed Fund Investment Committee. Previously, Barbara was CEO of Stabilitech, and she was Commercial Director at Arrow Therapeutics until the company was acquired by AstraZeneca. Barbara was also Senior Business Development Manager at Celltech. Barbara has a BA and D Phil in Chemistry from the University of Oxford, and is a Sloan Fellow from London Business School. Steve Bates, OBE CEO, BioIndustry Association Since his appointment as Chief Executive of the BioIndustry Association in 2012, Steve has led major BIA campaigns for, amongst other things, improved access to finance, the refilling of the Biomedical Catalyst, anti-microbial resistance and the opportunity the sector presents to generalist long term investors. Steve champions the adaptive pathway approach to the licensing of new drugs, the need for Early Access and is particularly proud of the working relationship the BIA has established with the UK’s leading medical research charities.
    [Show full text]
  • Applying Polygenic Risk Scoring for Psychiatric Disorders to a Large
    http://www.diva-portal.org This is the published version of a paper published in . Citation for the original published paper (version of record): de Jong, S., Abdalla Diniz, M J., Saloma, A., Gadelha, A., Santoro, M L. et al. (2018) Applying polygenic risk scoring for psychiatric disorders to a large family with bipolar disorder and major depressive disorder Communications Biology, 1: 163 https://doi.org/10.1038/s42003-018-0155-y Access to the published version may require subscription. N.B. When citing this work, cite the original published paper. Permanent link to this version: http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-157800 ARTICLE DOI: 10.1038/s42003-018-0155-y OPEN Applying polygenic risk scoring for psychiatric disorders to a large family with bipolar disorder and major depressive disorder Simone de Jong1,2, Mateus Jose Abdalla Diniz3,4, Andiara Saloma3,4, Ary Gadelha3, Marcos L. Santoro5, 1234567890():,; Vanessa K. Ota3,5, Cristiano Noto3, Major Depressive Disorder and Bipolar Disorder Working Groups of the Psychiatric Genomics Consortium#, Charles Curtis1,2, Stephen J. Newhouse2,6,7, Hamel Patel2,6, Lynsey S. Hall8, Paul F. O`Reilly1, Sintia I. Belangero3,5, Rodrigo A. Bressan3 & Gerome Breen 1,2 Psychiatric disorders are thought to have a complex genetic pathology consisting of interplay of common and rare variation. Traditionally, pedigrees are used to shed light on the latter only, while here we discuss the application of polygenic risk scores to also highlight patterns of common genetic risk. We analyze polygenic risk scores for psychiatric disorders in a large pedigree (n ~ 260) in which 30% of family members suffer from major depressive disorder or bipolar disorder.
    [Show full text]
  • Minutes of the Proceedings
    MINUTES OF THE PROCEEDINGS at the Thirty‐sixth Meeting of the COUNCIL of the IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE The Thirty‐sixth Meeting of the Council was held in the Council Room, 170 Queen’s Gate, South Kensington Campus, Imperial College London, at 10:00 a.m. on Friday, 16th May 2014, when there were present: The Baroness Manningham‐Buller (Chair), Professor A. Anandalingam, Mr. C. Brinsmead, Dame Ruth Carnall, Mrs. P. Couttie, Professor M.J. Dallman, Mr. P. Dilley, Mr. D. Goldsmith, Professor N. Gooderham, Professor Dame Julia Higgins, Professor D.P.A. Kelleher, Ms. J.R. Lomax, Professor J. Magee, Mr. J. Newsum, Mr. S. Newton, Ms. K. Owen, Mr. M. Sanderson, Professor J Stirling, the President & Rector and the Clerk to the Court and Council. Apologies Mr. I. Conn. MINUTES Council – 7th February 2014 1. The Minutes of the thirty‐fifth Meeting of the Council, held on Friday, 7th February 2014, were taken as read, confirmed and signed. CHAIR’S REPORT 2. The Chair advised members that, following his appointment as Chair of the Chelsea and Westminster Hospital NHS Foundation Trust, Sir Thomas Hughes‐Hallett had resigned as a co‐opted member of the Council on 11 February. PRESIDENT & RECTOR’S REPORT 3. The President & Rector reported that this year’s Imperial Festival, held on 9th and 10th May, had received many visitors at the South Kensington campus to enjoy the various demonstrations, talks 1 Council 16th May 2014 and other activities on offer. What had started as a relatively modest pilot project in 2012 to explore how Imperial College London might share its research with more people had now evolved into a large‐scale and prominent annual fixture in the College’s calendar.
    [Show full text]
  • Agenda for Change
    Incorporating Central Middlesex Hospital Community Services in Brent, Ealing and Harrow Ealing Hospital Northwick Park Hospital St. Mark’s Hospital DIVISION OF INTEGRATED MEDICINE JOB DESCRIPTION CONSULTANT IN RHEUMATOLOGY Page 1 of 26 Contract: Permanent Hours: Full Time Rota: None Intensity category: N/A On-call Availability supplement: N/A Responsible to: Clinical Director, Integrated Medicine Reporting to: Clinical Lead, Rheumatology Principal Location: London North West University Healthcare NHS Trust – Central Middlesex Hospital Tenure: Substantive Page 2 of 26 CONTENTS SUBJECT PAGE 1. Introduction to London North West 4 University Healthcare NHS Trust 2. Trust Management/Trust Board 7 3. Training and Education 8 4. Research 9 5. Healthcare Facilities 10 6. The Application Process 12 7. Particulars of the post and department 13 Appendix A – Job Plan 18 Appendix B – Person Specification 19 Appendix C – Terms and Conditions of Service 21 Page 3 of 26 1. INTRODUCTION THE TRUST London North West University Healthcare NHS Trust London North West University Healthcare NHS Trust is one of the largest integrated care Trusts in the country bringing together hospital and community services across the boroughs of Brent, Harrow and Ealing. Our 9,000 staff, including 1,300 doctors and 4,000 nurses and serves a diverse population of approximately 850,000.The Trust was established in October 2014 following the merger of The North West London Hospitals NHS Trust and Ealing Hospital NHS Trust and has an annual budget of over £640 million. This is a pivotal time for the Trust as we pursue a transformational programme of activity to improve the way healthcare is delivered across the acute and community settings in North West London.
    [Show full text]
  • Clinical Academic Leadership in COVID-19: a Rapid Leader: First Published As 10.1136/Leader-2020-000292 on 1 July 2020
    Brief report Clinical academic leadership in COVID-19: a rapid leader: first published as 10.1136/leader-2020-000292 on 1 July 2020. Downloaded from response to sharing emerging insights in intensive care Nirandeep Rehill,1,2 Amanda Begley,1 Katie Mantell,1 C Michael Roberts1 1UCL Partners, London, UK ABSTRACT assume that role. UCLPartners is a partnership of 2 NIHR Applied Health Research Background The COVID-19 pandemic has raised a 23 National Health Service (NHS) trusts and 9 North Thames, London, UK wide range of challenges for health systems around the higher education institutions covering north central world and the National Health Service in England has and east London and parts of Essex, Hertfordshire Correspondence to Dr Amanda Begley, UCL been no exception. A significant proportion of infected and Bedfordshire. Governed by a partnership board Partners, London W1T 7HA, UK; cases require intensive care unit support and have a high and led by clinical academics supported by a corpo- amanda. begley@ uclpartners. mortality rate. In the early stages of the pandemic, there rate senior team, its purpose is to bring together com was neither an evidence base nor a clinical consensus on organisations to work collaboratively for the health and care of the population served. Received 18 May 2020 the optimal management of patients in this setting. Revised 9 June 2020 Interventions Responding to requests for assistance Accepted 11 June 2020 to address this evidence gap, UCLPartners, an Academic SHARING EMERGING INSIGHTS Health Science Partnership, working in collaboration with Through our partnership, we received intelligence other organisations including National Institute of Health that clinicians were concerned that the traditional Research Applied Research Collaboration North Thames, management of ARDS and other complications was developed a clinical academic team to synthesise clinical not having expected outcomes against this novel learning in real time.
    [Show full text]
  • Issue 231 • 24 March 2011 Reportersharing Stories of Imperial’S Community News Makers
    Issue 231 • 24 March 2011 reporterSharing stories of Imperial’s community News makers Felix Editor Kadhim Shubber on the award-winning newspaper and the 135 students who make it happen > Centre pages plastic steering science from electronics engineering scratch Imperial ranked Professor Why does a in top three Jeff Magee rainforest have for materials on becoming greater capacity science Faculty Principal than a desert? PAGE 3 PAGE 10 PAGE 11 2 >> newsupdate www.imperial.ac.uk/reporter | reporter | 24 March 2011 • Issue 231 Duke of York witnesses healthcare innovations editor’s C orner His Royal Highness The Duke of industry, commerce and health- York (pictured far right) visited care has been central to its mis- Imperial on 2 March to learn about sion since its foundation in 1907. The Duke of York with Lord Ara Darzi and Professor Guang- Big picture the College’s pioneering health- Speaking at the end of his Zhong Yang in the Hamlyn Centre for Robotic Surgery. care innovations in the UK and tour, the Duke said: “Imperial has internationally. He heard about gripped the problem of being able natural disasters are the College’s international partner- to deliver its output internationally for International Trade and Investment, that emotive subjects. Since ships, visited early-stage compa- in a way that many other universi- what you do is utterly brilliant.” the massive earthquake nies in the Imperial Incubator and ties have not been able to achieve. The Duke was also given a tour of the shook Japan on 11 March, learnt about developing robotic It’s not just about education, it’s Incubator which houses 17 early-stage technol- the frightening scenes of technologies to enhance surgery.
    [Show full text]
  • Dr Charlie Davie, Managing Director, Uclpartners
    Collaborating with industry and researchers to deliver improved healthcare Dr Charlie Davie, Managing Director, UCLPartners UCLPartners – a partnership organisation Parts of London, Bedfordshire, Hertfordshire and Essex 6 million 46 11 population Healthcare Higher education organisations and partners clinical commissioners 844 100s 6 primary care practices industry partnerships Sustainability and Transformation Partnerships A unique business model UCLPartners aligns the following functions in one partnership: • Academic Health Science Centre (AHSC) • Academic Health Science Network (AHSN) • NIHR Collaboration for Applied Health Research and Care (CLAHRC/ARC) • Commercial Trials Prime Site • NIHR Clinical Research Network (CRN) • Genomic Medicine Centre 5 Life Sciences Industrial Strategy • Science: Continued support for the science base, maintaining strength and international competitiveness. • Growth: An environment that encourages companies to start and grow, building on strengths across the UK, including expansion of manufacturing in the sector. • NHS: NHS and industry collaboration, facilitating better care for patients through better adoption of innovative treatments and technologies. • Data: Making the best use of data and digital tools to support research and better patient care. • Skills: Ensuring that the sector has access to a pool of talented people to support its aims through a strong skills strategy. 6 7 The Accelerated Access Review Aim: To speed up access to innovation and grow the UK life sciences industry Recommendations in five key areas: 1. Patients, clinicians and charities to be the key drivers in innovation 2. A new accelerated access pathway will prioritise innovations 3. Open and transparent pathways to bring forward medtech, digital and diagnostics 4. Driving innovation through NHS planning, increasing capacity, clinical leadership and incentives 5.
    [Show full text]
  • Health Tech Innovator Drdoctor Gains Three New NHS Contracts
    Press release Health tech innovator DrDoctor gains three new NHS contracts Patient appointment innovator DrDoctor is working with three new major NHS Trusts: • A major children’s hospital, where the system is being configured in record time and will manage the Trust’s 150000 specialist outpatient appointments • Whittington Health NHS Trust, covering all appointments across the Trust • University Hospital Southampton NHS Foundation Trust, DrDoctor is piloting in Paediatrics to demonstrate an estimated 30% DNA rate reduction DrDoctor supports hospitals with digital transformation. Its system allows patients to view, change and schedule outpatient appointments themselves, online, on smartphone or by conversational SMS. DrDoctor chief executive Tom Whicher said: “We are thrilled to support three more forward thinking Trusts in their journey to provide effective, digital first, patient centric services. All three implementations will deliver, in year cash savings, increase patient satisfaction and form a strong foundation for future digital transformation.” DrDoctor reduces the number of missed and unscheduled appointments and allows patients to opt in to receiving paperless communications, releasing print and postage savings to Trusts. New analysis at Guy’s and St Thomas’ NHS Foundation Trust has revealed that in one year the Trust has saved £2.2m, and patient satisfaction is 96 percent. DrDoctor is supporting a major London children’s hospital’s strategic plan to become the leading paediatric centre in the world. DrDoctor was engaged in January 2017 to deploy its Appointment Management Platform. DrDoctor’s platform is a fundamental shift away from an inconsistent approach to appointment management. The platform will go-live in the summer of 2017.
    [Show full text]
  • Developing the Evidence Base for London's Local Industrial Strategy
    Developing the evidence base for London’s Local Industrial Strategy - Interim report August 2019 Developing the evidence base for London’s Local Industrial Strategy - Interim report copyright Greater London Authority August 2019 Published by Greater London Authority City Hall The Queens Walk London SE1 2AA www.london.gov.uk Tel 020 7983 4000 Minicom 020 7983 4000 ISBN 978-1-84781-719-8 Cover photograph © Shutterstock For more information about this publication, please contact: GLA Economics Tel 020 7983 4000 Email [email protected] GLA Economics provides expert advice and analysis on London’s economy and the economic issues facing the capital. Data and analysis from GLA Economics form a basis for the policy and investment decisions facing the Mayor of London and the GLA group. GLA Economics uses a wide range of information and data sourced from third party suppliers within its analysis and reports. GLA Economics cannot be held responsible for the accuracy or timeliness of this information and data. The GLA will not be liable for any losses suffered or liabilities incurred by a party as a result of that party relying in any way on the information contained in this report. Acknowledgements GLA Economics would like to thank all colleagues at the GLA and in other organisations who contributed to this report, including: • Members of the Analytical Working Group, especially the ONS regional statisticians (Sukriti Verma and Tom Liu) for all their work on developing London-relevant statistics; • Gerard Burgess and Jorn Peters in the GLA Planning Directorate for their very valuable comments and contributions to Chapters 7 and 8; • Professor Stephen Roper at the Enterprise Research Centre (Warwick Business School) for his valuable advice on Chapter 6; • The LIS Evidence Base Independent Expert Panel – Professor Riccardo Crescenzi, Dr.
    [Show full text]
  • Self-Care in Young People with Diabetes: a Qualitative Exploration Using a Salutogenic Approach
    SELF-CARE IN YOUNG PEOPLE WITH DIABETES: A QUALITATIVE EXPLORATION USING A SALUTOGENIC APPROACH EMMA GREEN A thesis submitted in partial fulfilment of the requirements of the University of East London for the degree of Doctor of Philosophy September 2018 Abstract This thesis investigates experiences of self-care amongst young people with diabetes using a qualitative salutogenic approach. Diabetes self-care includes injecting insulin, counting carbohydrates, attending hospital check-ups and other activities to maintain stable blood sugar levels. Optimal blood sugar levels are not always easy for young people with diabetes to attain, placing them at increased risk of health complications. A lack of self-care has been assumed traditionally to indicate a lack of knowledge. This exemplifies a ‘deficit’ approach whereby efforts to improve self-care focus heavily on diabetes education to increase knowledge. However, there is a lack of evidence that young people lack diabetes knowledge or that education-only interventions are effective. This thesis applies salutogenesis as an alternative to the deficit approach in which young people are conceptualised as individuals and their capabilities are acknowledged. The empirical work undertaken includes: a meta-ethnography of the international qualitative literature, analysis of semi-structured interviews with young people living in a diverse urban area of the UK, defined as disengaged from diabetes self-care (N=14): and a qualitative study conducted with young people participating in novel salutogenic projects which focused on their capabilities rather than ‘correcting’ their deficits (N=5). Across the studies it was found that ‘identity work’ underpins young people’s experiences with diabetes self-care.
    [Show full text]